Page last updated: 2024-12-05
2-propenylurea
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11181 |
SCHEMBL ID | 29510 |
MeSH ID | M0251248 |
Synonyms (50)
Synonym |
---|
unii-0czm19wlk8 |
4-04-00-01070 (beilstein handbook reference) |
urea, n-2-propen-1-yl- |
0czm19wlk8 , |
nsc136617 |
nsc-136617 |
monoallylurea |
wln: zvm2u1 |
n-2-propenylurea |
urea, allyl- |
n-allylurea |
nsc7607 |
1-allylurea |
urea, 2-propenyl- |
allylurea |
nsc-7607 |
allylcarbamide |
557-11-9 |
inchi=1/c4h8n2o/c1-2-3-6-4(5)7/h2h,1,3h2,(h3,5,6,7 |
2-propenylurea |
brn 1745068 |
ccris 5958 |
nsc 7607 |
ai3-23204 |
einecs 209-157-1 |
n-allylurea, 95% |
allyl urea |
A0237 |
prop-2-enylurea |
AKOS000120511 |
allyl-urea |
BBL011340 |
STL146430 |
1-prop-2-en-1-ylurea |
FT-0622059 |
n-2-propen-1-ylurea |
allylurea [mi] |
(prop-2-en-1-yl)urea |
SCHEMBL29510 |
DTXSID2024450 |
Z56904662 |
allylharnstoff |
CS-0197283 |
VS-02926 |
mfcd00007954 |
EN300-17276 |
Q27236625 |
D88233 |
A936820 |
SY049387 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |